Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 232.94x is 593% above its 1-year average of 33.60x, near the high end of its 1-year range (-165.74x–232.94x).
As of the fiscal period ended Sunday, December 31, 2017.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
232.94x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 463 covered companies
CURRENT VS SECTOR MEDIAN
+4222.88%
vs the sector median at left
Boundless Bio, Inc.
Market Cap
$57.65M
Interest Coverage Ratio
232.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.81M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.98M
Interest Coverage Ratio
-17.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.57M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.39M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.95M
Interest Coverage Ratio
-3392.06x
TTM Avg
18.65x
3Y Avg
15.79x
5Y Avg
19.13x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.65M | 232.94x | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.81M | N/A | N/A | N/A | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | -17.93x | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.66M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $60.39M | -5.91x | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.78M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.95M | -3392.06x | 18.65x | 15.79x | 19.13x |
| Aldeyra The (ALDX)vs › | $54.74M | -18.51x | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.34M | -31.98x | N/A | N/A | N/A |
Interest Coverage
232.9x
Debt/Equity
0.00
Current Ratio
9.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2017-12-31 | 232.94x |
| 2017-09-30 | -165.74x |
